1. Role of EFNA1 in tumorigenesis and prospects for cancer therapy
    Yongping Hao et al, 2020, Biomedicine & Pharmacotherapy CrossRef
  2. Roles of EphA1/A2 and ephrin‐A1 in cancer
    Katsuaki Ieguchi et al, 2019, Cancer Science CrossRef
  3. Resveratrol inhibits IL‐6‐induced ovarian cancer cell migration through epigenetic up‐regulation of autophagy
    Alessandra Ferraresi et al, 2017, Molecular Carcinogenesis CrossRef
  4. Overexpression of microRNA-133b is associated with the increased survival of patients with hepatocellular carcinoma after curative hepatectomy: Involvement of the EGFR/PI3K/Akt/mTOR signaling pathway
    Xuedong Wang et al, 2017, Oncology Reports CrossRef
  5. A Five-Genes-Based Prognostic Signature for Cervical Cancer Overall Survival Prediction
    Menghuang Zhao et al, 2020, International Journal of Genomics CrossRef
  6. Waldenström Macroglobulinemia: Mechanisms of Disease Progression and Current Therapies
    Ava J. Boutilier et al, 2022, International Journal of Molecular Sciences CrossRef
  7. Analysis of ADAM12-Mediated Ephrin-A1 Cleavage and Its Biological Functions
    Katsuaki Ieguchi et al, 2021, International Journal of Molecular Sciences CrossRef
  8. Inhibition of angiogenesis by leflunomide via targeting the soluble ephrin-A1/EphA2 system in bladder cancer
    Maolin Chu et al, 2018, Scientific Reports CrossRef
  9. Integrative genomics analysis of hub genes and their relationship with prognosis and signaling pathways in esophageal squamous cell carcinoma
    Fang‑Fang Chen et al, 2019, Molecular Medicine Reports CrossRef
  10. Eph/Ephrin Signaling in the Tumor Microenvironment
    Katsuaki Ieguchi et al, 2021, Tumor Microenvironment CrossRef
  11. The Clinical Impact of the EPH/Ephrin System in Cancer: Unwinding the Thread
    Alexandros Pergaris et al, 2021, International Journal of Molecular Sciences CrossRef
  12. EFNA1in gastrointestinal cancer: Expression, regulation and clinical significance
    Ling-Yu Chu et al, 2022, World Journal of Gastrointestinal Oncology CrossRef
  13. EFNA3 Is a Prognostic Biomarker Correlated With Immune Cell Infiltration and Immune Checkpoints in Gastric Cancer
    Peng Zheng et al, 2022, Frontiers in Genetics CrossRef
  14. Expression characteristic, immune signature, and prognosis value of EFNA family identified by multi-omics integrative analysis in pan-cancer
    Zonglin Jiao et al, 2022, BMC Cancer CrossRef
  15. Unraveling the Significance of EPH/Ephrin Signaling in Liver Cancer: Insights into Tumor Progression and Therapeutic Implications
    Stavros P. Papadakos et al, 2023, Cancers CrossRef
  16. EFNA1 is a potential key gene that correlates with immune infiltration in low-grade glioma
    Yong-Ping Hao et al, 2021, Medicine CrossRef
  17. Overexpression and correlation of HIF-2α, VEGFA and EphA2 in residual hepatocellular carcinoma following high-intensity focused ultrasound treatment: Implications for tumor recurrence and progression
    Lun Wu et al, 2017, Experimental and Therapeutic Medicine CrossRef
  18. Effects of EFNA1 on cell phenotype and prognosis of esophageal carcinoma
    Yongqiang Zhang et al, 2021, World Journal of Surgical Oncology CrossRef
  19. The Eph/Ephrin System in Hepatocellular Carcinoma: Functional Roles and Potential Therapeutic Targets
    Xin Shu et al, 2022, Oncologie CrossRef
  20. Comprehensive analysis of the expression and prognosis for TNFAIPs in head and neck cancer
    Gaochen Lan et al, 2021, Scientific Reports CrossRef
  21. An integrated analysis of single-cell and bulk transcriptomics reveals EFNA1 as a novel prognostic biomarker for cervical cancer
    Xiaopeng Shen et al, 2022, Human Cell CrossRef
  22. A comprehensive prognostic and immunological analysis of ephrin family genes in hepatocellular carcinoma
    Shenglan Huang et al, 2022, Frontiers in Molecular Biosciences CrossRef